Tesamorelin + Ipamorelin Blend Dosage: Research Protocol Comparison
| Protocol | Tesamorelin Dose | Ipamorelin Dose | Total Daily Peptide | Injection Frequency | Typical IGF-1 Increase | Bottom Line ||—|—|—|—|—|—|| Conservative Start | 250mcg | 250mcg | 500mcg | Once daily (AM fasted) | +60–80ng/mL | Best for first-time users
This comparison does not assign a generated winner or score.
- | Protocol | Tesamorelin Dose | Ipamorelin Dose | Total Daily Peptide | Injection Frequency | Typical IGF-1 Increase | Bottom Line ||—|—|—|—|—|—|| Conservative Start | 250mcg | 250mcg | 500mcg | Once daily (AM fasted) | +60–80ng/mL | Best for first-time users assessing GH responsiveness. Low side effect risk || Standard Growth | 250mcg | 250mcg | 1000mcg | Twice daily (AM + post-training) | +120–160ng/mL | The most commonly used research protocol for muscle hypertrophy goals || Pulse-Optimised | 200mcg | 400mcg | 1200mcg | Twice daily (AM + post-training) | +140–180ng/mL | Higher Ipamorelin ratio maximises pulse amplitude without cortisol elevation || High-Intensity | 300mcg | 500mcg | 1600mcg | Twice daily (AM + post-training) | +160–200ng/mL | Used in advanced protocols. Requires IGF-1 and glucose monitoring |